The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Biotechnology-Research > Celera Genomics Group

Celera Genomics Group
NYSE: CRA
Change
symbol:
     
 NEWS FROM THE WIRES
Private capital seen as aid to stem cell research
Aug 14 2001 03:18 PM PDT

Applied Biosystems seeks approval for HIV test
Jul 31 2001 02:15 PM PDT

Oxford GlycoSciences' machine finds proteins -- fast
Jul 27 2001 02:23 PM PDT

Celera loss widens, Applied Biosystems profit falls
Jul 26 2001 09:52 AM PDT

Eurostocks pick up steam, no earnings disasters
Jul 26 2001 04:04 AM PDT

More WIRE STORIES about this company

 NEWS FROM THE STANDARD
Biotech: Celera is Snippy
Jul 30 2001 12:00 AM PDT

Celera Enters a New Genome Race
Jul 24 2001 05:52 PM PDT

Celera Catches the Drug Bug
Jun 13 2001 04:27 PM PDT

Building a Better Bio-Supercomputer
Jun 11 2001 12:00 AM PDT

IBM's Biotech Ambitions
Jun 04 2001 12:00 AM PDT

 PROFILE
Celera Genomics Group cleared a major hurdle when it mapped the human genome, and the company remains a leader in the biotechnology race. The unit of Applera (formerly PE Corporation) continues to explore not just the human genome (SNPs, or single nucleotide polymorphisms that create genetic individuality, are also a focus) but also the genetic stuff of mice, fruit flies (it has mapped the "Drosophila" genome), and other life forms. Celera licenses access to its genomics databases to biotech and drug firms, research organizations, and other life sciences firms. Working with Applera and sister firm Applied Biosystems, the company will develop new drugs based on their combined genomics research.

 COMPETITION
Genset, S.A. (GENXY)
IMPATH Inc. (IMPH)
Incyte Genomics, Inc. (INCY)

 STOCK ANALYSIS
 View by:
 Day 
 Day 
 Month 
 Month 
 Year 
 Year 
FURTHER ANALYSIS
• Advanced Charting
• Deals

 FINANCIAL OVERVIEW
Fiscal Year-End: June
2001 Sales (mil.): 89.40
1-Yr. Sales Growth: 109.4%
Employees: 359
Revenue per employee: $249,025.07

 KEY PEOPLE
• J. Craig Venter
    CEO
• Ugo DeBlasi
    CFO

 CONTACT INFO
45 W. Gude Dr.
Rockville, MD 20850
US
Phone: 240-453-3000
Fax: 240-453-4000
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001